APA (7th ed.) Citation

RF, S., S, H., RA, H., S, H., RG, W., G, P., . . . CP, C. (2007). Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes. Journal of the American College of Cardiology (JACC), 50(19), 1852. https://doi.org/10.1016/j.jacc.2007.07.058

Chicago Style (17th ed.) Citation

RF, Storey, et al. "Inhibition of Platelet Aggregation by AZD6140, a Reversible Oral P2Y12 Receptor Antagonist, Compared with Clopidogrel in Patients with Acute Coronary Syndromes." Journal of the American College of Cardiology (JACC) 50, no. 19 (2007): 1852. https://doi.org/10.1016/j.jacc.2007.07.058.

MLA (9th ed.) Citation

RF, Storey, et al. "Inhibition of Platelet Aggregation by AZD6140, a Reversible Oral P2Y12 Receptor Antagonist, Compared with Clopidogrel in Patients with Acute Coronary Syndromes." Journal of the American College of Cardiology (JACC), vol. 50, no. 19, 2007, p. 1852, https://doi.org/10.1016/j.jacc.2007.07.058.